Oncostatin M receptor-β signaling limits monocytic cell recruitment in acute inflammation

Journal of Immunology

Volumn 181, Issue 3, 2008, Pages 2174-2180

  Hams, Emily ^a   Colmont, Chantal S ^a   Dioszeghy, Vincent ^a   Hammond, Victoria J ^a   Fielding, Ceri A ^a   Williams, Anwen S ^a   Tanaka, Minoru ^b   Miyajima, Atsushi ^b   Taylor, Philip R ^a   Topley, Nicholas ^a   Jones, Simon A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ONCOSTATIN M RECEPTOR BETA; RANTES; CHEMOKINE; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; MESOTHELIUM CELL; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM; PERITONEUM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS EPIDERMIDIS; WILD TYPE; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NF-KAPPA B; ONCOSTATIN M RECEPTOR BETA SUBUNIT; SIGNAL TRANSDUCTION;

EID: 49649086186     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.3.2174     Document Type: Article

References (47)

1. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
2. Heinrich, P. C., I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper. 2003. Principles of interleukin-6-type cytokine signalling and its regulation. Biochem. J. 374: 1-20.
3. Ernst, M., and B. J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gp130 Trends Genet. 20: 23-32.
4. Zarling, J., H. Shoyab, M. B. Marquardt, M. Hanson, N. Lioubin, and G. J. Todaro. 1986. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83: 9739-9743.
5. Wahl, A. F., and P. M. Wallace. 2001. Oncostatin M in the anti-inflammatory response. Ann. Rheum. Dis. 60: iii75-iii80.
6. Wallace, P. M., J. F. McMaster, K. A. Rouleau, T. J. Brown, K. J. Loy, K. L. Donaldson, and A. F. Wahl. 1999. Regulation of inflammatory responses by oncostatin M. J. Immunol. 162: 5547-5555.
7. Modur, V., M. J. Feldhaus, A. S. Weyrich, D. L. Jicha, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1997. Oncostatin M is a proinflammatory mediator: in vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J. Clin. Invest. 100: 158-168.
8. Ihn, H., and K. Tamaki. 2000. Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J. Immunol. 165: 2149-2155.
9. Langdon, C., C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards. 2000. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am. J. Pathol. 157: 1187-1196.
10. Bernad, A., M. Kopf, R. Kulbacki, N. Weich, G. Koehler, and J. C. Gutierrez-Ramos. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1: 725-731.
11. Nandurkar, H. H., L. Robb, D. Tarlinton, L. Barnett, F. Kontgen, and C. G. Begley. 1997. Adult mice with targeted mutation of the interleukin-11 receptor (IL-11Ra) display normal hematopoiesis. Blood 90: 2148-2159.
12. Escary, J. L., J. Perreau, D. Dumerill, S. Ezine, and P. Brulet. 1993. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363: 361-364.
13. Tanaka, M., Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima. 2003. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 102: 3154-3162.
14. Jenkins, B. J., A. W. Roberts, C. J. Greenhill, M. Najdovska, T. Lundgren-May, L. Robb, D. Grail, and M. Ernst. 2007. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood 102: 2380-2388.
15. Modur, V., Y. Li, G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre. 1997. Retrograde inflammatory signalling from neutrophils to endothelial cells by soluble interleukin-6 receptor α. J. Clin. Invest. 100: 2752-2756.
16. Hurst, S. M., R. M. McLoughlin, J. Monslow, L. Morgan, S. Owens, G. M. Fuller, N. Topley and S. A. Jones. 2002. Secretion of oncostatin-M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J. Immunol. 169: 5244-5251.
17. McLoughlin, R. M., S. M. Hurst, M. A. Nowell, D. A. Harris, S. Horiuchi, L. Morgan, T. S. Wilkinson, N. Yamamoto, N. Topley, and S. A. Jones. 2004. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J. Immunol. 172: 5676-5683.
18. Nowell, M. A., P. J. Richards, C. A. Fielding, S. Ognjanoviv, N. Topley, A. S. Williams, G. Bryant-Greenwood, and S. A. Jones. 2006. Regulation of pre-B cell colony-enhancing factor by STAT3-dependent interleukin-6 trans-signaling. Arthritis Rheum. 54: 2084-2095.
19. Wong, P. K. K., J. M. W. Quinn, N. A. Sims, A. van Nieuwenhuijze, I. K. Campbell, and I. P. Wicks. 2006. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 54: 158-168.
20. Richards, C. D., C. Langdon, F. Botelho, and T. J. Brown. 1996. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony stimulating factor by synovial and lung fibroblasts. J. Immunol. 156: 343-349.
21. Langdon, C., J. Leith, F. Smith, and C. D. Richards. 1997. Oncostatin M stimulates monocyte chemoattractant protein-1 and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum. 40: 2139-2146.
22. Hurst, S. M., T. S. Wilkinson, R. M. McLoughlin, S. Jones, S. Horiuchi, N. Yamamoto, S. Rose-John, G. M. Fuller, N. Topley, and S. A. Jones. 2001. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14: 705-714.
23. McLoughlin, R. M., B. J. Jenkins, D. Grail, A. S. Williams, C. A. Fielding, C. R. Parker, M. Ernst, N. Topley, and S. A. Jones. 2005. IL-6 trans-signalling via STAT3 directs T-cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. USA 102: 9589-9594.
24. Jones, S. A. 2005. Transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175: 3463-3468.
25. Topley, N., Z. Brown, A. Jörres, J. Westwick, M. Davies, G. A. Coles, and J. D. Williams. 1993. Human peritoneal mesothelial cells synthesize IL-8: Synergistic induction by interleukin-1β and tumor necrosis factor α. Am. J. Pathol. 142: 1876-1886.
26. Taylor, P. R., G. D. Brown, A. B. Geldhof, L. Martinez-Pomares, and S. Gordon. 2003. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 33: 2090-2097.
27. Sultan, A. M., C. J. Dunn, P. C. Mimms, J. P. Giroud, and D. A. Willoughby. 1978. The leucocyte disappearance reaction in non-immune acute inflammation. J. Physiol. 126: 221-230.
28. Topley, N., T. Liberek, A. Davenport, F. K. Li, and J. D. Williams. 1996. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int. 56: S17-21.
29. Dillon, S. R., C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, S. R. Presnell, H. S Haugen, M. Maurer, B. Harder, J. Johnston, et al. 2004. Interleukin-31, a cytokine produced by activated T-cells, induces dermatitis in mice. Nat. Immunol. 5: 752-760.
30. Williams, J. D., K. J. Craig, C. von Ruhland, N. Topley, and G. T. Williams. 2003. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int. 64: S43-S49.
31. Grenier, A., D. Combaux, J. Chastre, M. A. Gougerot-Pocidalo, C. Gibert, M. Dehoux, and S. Chollet-Martin. 2001. Oncostatin M production by blood and alveolar neutrophils during acute lung injury. Lab. Invest. 81: 133-141.
32. Koshy, P. J., N. Henderson, C. Logan, P. F. Life, T. E. Cawston, and A. D. Rowan. 2002. Interleukin-17 induces cartilage breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum. Dis. 61: 704-713.
33. Hui, W., A. D. Rowan, C. D. Richards, and T. E. Cawston. 2003. Oncostatin-M in combination tumor necrosis factor α induces cartilage damage and matrix metalloprotease expression in vitro and in vivo. Arthritis Rheum. 48: 3404-3418.
34. Plater-Zyberk, C., J. Buckton, S. Thompson, J. Spaull, E. Zanders, J. Papworth, and P. F. Life. 2001. Amelioration of arthritis in two murine models using antibodies to oncostatin-M. Arthritis Rheum. 44: 2697-2702.
35. De Hooge, A. S. K., F. A. J. van de Loo, M. B. Bennink, O. J. Arntz, T. J. W. Fiselier, M. J. A. M. Franssen, L. A. B. Joosten, P. L. E. M. van Lent, C. D. Richards, and W. B. van der Berg. 2003. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin-M: a comparative study in gene-deficient mice. Arthritis Rheum. 48: 1750-1761.
36. Diveu, C., E. Lelievre, D. Perret, A.-H. L. Lak-Hal, J. Froger, C. Guillet, S. Chevalier, F. Rousseau, A. Wesa, L. Preisser, et al. 2003. GPL, a novel cytokine receptor related to gp130 and leukaemia inhibitory factor receptor. J. Biol. Chem. 278: 49850-49859.
37. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates the immune response. Nat. Rev. Immunol. 2: 965-975.
38. Fantuzzi, L., P. Borghi, V. Cioli, G. Pavlakis, F. Belardelli, and S. Gessan. 1999. Loss of CCR2 expression and functional response to moncyte chemotactic factor (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood 94: 875-883.
39. Kaufmann, A., R. Salentin, D. Gemsa, and H. Sprenger. 2001. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1α during differentiation of human monocytes to macrophages. J. Leukocyte Biol. 69: 248-252.
40. Tanigawa, T., N. Nicola, G. A. McArthur, A. Strasser, and C. G. Begley. 1995. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood 85: 379-390.
41. Clutterbuck, R., R. Powles, J. Millar, and D. Catovsky. 2000. Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells. Exp. Hematol. 28: 1120-1128.
42. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2001. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1: 510-514.
43. Jenkins, B. J., D. Grail, M. Inglese, C. Quilici, S. Bozinovski, P. Wong, and M. Ernst. 2004. Imbalanced gp130-dependent signalling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression. Mol. Cell. Biol. 24: 1453-1463.
44. Kitamura, H., H. Kamon, S.-I. Sawa, S.-J. Park, N. Katunuma, K. Ishihara, M. Murakami, and T. Hirano. 2005. IL-6-STAT3 controls intracellular MHC class II αβ dimmer level through cathepsin S activity in dendritic cells. Immunity 23: 491-502.
45. Zhang, Z., and G. M. Fuller. 1997. The competitive binding of STAT3 and NF-κB on an overlapping DNA binding site. Biochem. Biophys. Res. Commun. 237: 90-94.
46. Yu, Z., W. Zhang, and B. C. Kone. 2002. Signal transducers and activators of transcription 3 STAT3 inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem. J. 367: 97-105.
47. Yang, J., X. Liao, M. K. Agarwal, L. Barnes, P. E. Auron, and G. R. Stark. 2007. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding NFκB. Genes Dev. 21: 1396-1408.